<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Antimicrob Agents Chemother</journal-id>
<journal-id journal-id-type="iso-abbrev">Antimicrob. Agents Chemother</journal-id>
<journal-id journal-id-type="hwp">aac</journal-id>
<journal-id journal-id-type="pmc">aac</journal-id>
<journal-id journal-id-type="publisher-id">AAC</journal-id>
<journal-title-group>
<journal-title>Antimicrobial Agents and Chemotherapy</journal-title>
</journal-title-group>
<issn pub-type="ppub">0066-4804</issn>
<issn pub-type="epub">1098-6596</issn>
<publisher>
<publisher-name>American Society for Microbiology</publisher-name>
<publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31844000</article-id>
<article-id pub-id-type="pmc">7038244</article-id>
<article-id pub-id-type="publisher-id">01168-19</article-id>
<article-id pub-id-type="doi">10.1128/AAC.01168-19</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Minireview</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>100 Years of Suramin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Wiedemar</surname>
<given-names>Natalie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hauser</surname>
<given-names>Dennis A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0003-3122-1941</contrib-id>
<name>
<surname>Mäser</surname>
<given-names>Pascal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<aff id="aff1">
<label>a</label>
<addr-line>Swiss Tropical and Public Health Institute, Department of Medical Parasitology and Infection Biology, Basel, Switzerland</addr-line>
</aff>
<aff id="aff2">
<label>b</label>
<addr-line>University of Basel, Basel, Switzerland</addr-line>
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address correspondence to Pascal Mäser, <email>pascal.maeser@unibas.ch</email>.</corresp>
<fn fn-type="other">
<p><bold>Citation</bold> Wiedemar N, Hauser DA, Mäser P. 2020. 100 years of suramin. Antimicrob Agents Chemother 64:e01168-19. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.01168-19">https://doi.org/10.1128/AAC.01168-19</ext-link>.</p>
</fn>
</author-notes>
<pub-date pub-type="epreprint">
<day>16</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>2</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2020</year>
</pub-date>
<volume>64</volume>
<issue>3</issue>
<elocation-id>e01168-19</elocation-id>
<permissions>
<copyright-statement>Copyright © 2020 American Society for Microbiology.</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>American Society for Microbiology</copyright-holder>
<license license-type="asm" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">
<license-p><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/ASMCopyrightv2">All Rights Reserved</ext-link>.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="AAC.01168-19.pdf"></self-uri>
<abstract abstract-type="precis">
<p>Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by <named-content content-type="genus-species">Trypanosoma brucei</named-content>
<italic>rhodesiense</italic>. Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism.</p>
</abstract>
<abstract>
<title>ABSTRACT</title>
<p>Suramin is 100 years old and is still being used to treat the first stage of acute human sleeping sickness, caused by <named-content content-type="genus-species">Trypanosoma brucei</named-content>
<italic>rhodesiense</italic>. Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite, and autism. Suramin is also an enigmatic molecule: What are its targets? How does it get into cells in the first place? Here, we provide an overview of the many different candidate targets of suramin and discuss its modes of action and routes of cellular uptake. We reason that, once the polypharmacology of suramin is understood at the molecular level, new, more specific, and less toxic molecules can be identified for the numerous potential applications of suramin.</p>
</abstract>
<kwd-group>
<title>KEYWORDS</title>
<kwd>
<italic>Trypanosoma brucei</italic>
</kwd>
<kwd>human African trypanosomiasis</kwd>
<kwd>polypharmacology</kwd>
<kwd>sleeping sickness</kwd>
<kwd>suramin</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<institution-wrap>
<institution>Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF)</institution>
<institution-id>https://doi.org/10.13039/501100001711</institution-id>
</institution-wrap>
</funding-source>
<award-id>310030_156264</award-id>
<principal-award-recipient>
<name>
<surname>Mäser</surname>
<given-names>Pascal</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="4"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="187"></ref-count>
<page-count count="14"></page-count>
<word-count count="10292"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>March 2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>